Brilacidin: Phase IIb started

Cellceutix began a double-blind, U.S. Phase IIb trial to compare single IV doses of 0.6 and 0.8 mg/kg brilacidin and 0.6 mg/kg IV brilacidin

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE